Learn More
Medchemexpress LLC Ym-53601 | 182959-33-7 | 99.4% | 372.86 g/mol | C21H22ClFN2O | 5 MG

Supplier: Medchemexpress LLC HY100313A5MG
YM-53601 is a potent squalene synthase (FDFT1) inhibitor with demonstrated in vivo lipid-lowering activity. It reduces plasma cholesterol and triglyceride levels and inhibits squalene synthase derived from human hepatoma cells (reported IC50 79 nM), making it useful as a biochemical tool to probe sterol biosynthesis and related pathways.
- Potent squalene synthase inhibitor with reported IC50 of 79 nM.
- Demonstrated to reduce plasma cholesterol and triglyceride levels in vivo.
- Inhibits farnesyl-diphosphate farnesyltransferase 1 enzyme activity.
- Solid, white to light brown, supplied in small research quantities.
- High purity (batch specific), typically reported ~99.4%.
- Soluble in DMSO (100 mg/mL); store solid at 4°C and solutions at -20°C to -80°C.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.